Javascript must be enabled to continue!
Evaluation of Inhaler Technique In COPD And Asthma Patients
View through CrossRef
Background: Asthma and COPD remain poorly controlled diseases that significantly affect the quality of life of patients. Inhalers are the main therapeutic options. Poor inhaler technique is a major factor that leads to poor clinical consequences, affecting the effectiveness of treatment and further control of symptoms. Aim of the Study: the present study aims at evaluating the inhaler technique and its clinical consequence in COPD and asthma patients .Patients and Methods: This is a cross sectional study of 70 patients, 35 with COPD and 35 with Asthma, who are already on inhaler drugs in their treatment. The use of inhaler was evaluated by a checklist that contains seven steps of inhaler use; by asking the patients to use their inhalers as usual, the correct or incorrect steps were recorded. The result of each patient checklist was correlated with the patient demographic parameters and level of control of his disease (COPD or asthma) by using COPD assessment test (CAT) or asthma control test (ACT) respectively. The Results: A total of 70 patients were enrolled in this study; 35 had COPD and 35 were asthmatic. The COPD patients were significantly older than asthmatic, mean age was 65.5 ± 5.8 (range: 55 – 75) years and 36.4 ± 13.9 (range: 16 – 65) years, respectively. (P. value < 0.05). Males were dominant among COPD patients than asthmatic group; they contribute to 80% and 45.7%, respectively,(P. value < 0.05). The level of education was not significantly different between the groups (P > 0.05). Current smokers were significantly more frequent in COPD group than in asthmatic group, 40% vs. 14.3%, respectively. The duration of inhaler use was significantly longer in asthmatics than in the COPD group members; the mean duration of use was 5.2 ± 4.5 (range: 1 – 20) years in asthmatic compared to 2.4 ± 1.1 (range: 1 – 6) years in COPD group. Dry powder inhalers (DPI) were relatively more frequently used than metered dose inhalers (MDI) where DPI used by 51.4% and 54.3% in COPD and asthmatic group, respectively. The level of education of patients and longer duration of inhaler use correlate positively with good technique, while no significant correlation with other variables. Conclusion: A large proportion of the participants had a poor inhaler technique regardless of the type of disease and of inhaler (DPI or MDI). There was a positive correlation between proper use of inhaler and high educational level of patients and longer duration of use.
Title: Evaluation of Inhaler Technique In COPD And Asthma Patients
Description:
Background: Asthma and COPD remain poorly controlled diseases that significantly affect the quality of life of patients.
Inhalers are the main therapeutic options.
Poor inhaler technique is a major factor that leads to poor clinical consequences, affecting the effectiveness of treatment and further control of symptoms.
Aim of the Study: the present study aims at evaluating the inhaler technique and its clinical consequence in COPD and asthma patients .
Patients and Methods: This is a cross sectional study of 70 patients, 35 with COPD and 35 with Asthma, who are already on inhaler drugs in their treatment.
The use of inhaler was evaluated by a checklist that contains seven steps of inhaler use; by asking the patients to use their inhalers as usual, the correct or incorrect steps were recorded.
The result of each patient checklist was correlated with the patient demographic parameters and level of control of his disease (COPD or asthma) by using COPD assessment test (CAT) or asthma control test (ACT) respectively.
The Results: A total of 70 patients were enrolled in this study; 35 had COPD and 35 were asthmatic.
The COPD patients were significantly older than asthmatic, mean age was 65.
5 ± 5.
8 (range: 55 – 75) years and 36.
4 ± 13.
9 (range: 16 – 65) years, respectively.
(P.
value < 0.
05).
Males were dominant among COPD patients than asthmatic group; they contribute to 80% and 45.
7%, respectively,(P.
value < 0.
05).
The level of education was not significantly different between the groups (P > 0.
05).
Current smokers were significantly more frequent in COPD group than in asthmatic group, 40% vs.
14.
3%, respectively.
The duration of inhaler use was significantly longer in asthmatics than in the COPD group members; the mean duration of use was 5.
2 ± 4.
5 (range: 1 – 20) years in asthmatic compared to 2.
4 ± 1.
1 (range: 1 – 6) years in COPD group.
Dry powder inhalers (DPI) were relatively more frequently used than metered dose inhalers (MDI) where DPI used by 51.
4% and 54.
3% in COPD and asthmatic group, respectively.
The level of education of patients and longer duration of inhaler use correlate positively with good technique, while no significant correlation with other variables.
Conclusion: A large proportion of the participants had a poor inhaler technique regardless of the type of disease and of inhaler (DPI or MDI).
There was a positive correlation between proper use of inhaler and high educational level of patients and longer duration of use.
Related Results
Influence of Gender on Inhaler Technique
Influence of Gender on Inhaler Technique
BACKGROUND:
This study was designed to evaluate the influence of gender on the inhaler technique of subjects on inhaler therapy and to determine the factors pre...
Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Innate immunity and its link to clinical outcomes in smokers with and without COPD
Innate immunity and its link to clinical outcomes in smokers with and without COPD
<p dir="ltr">Chronic obstructive pulmonary disease (COPD) is the fourth most common causes of death globally, affecting around ten percent of the adult population. Patients w...
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Irreversible Airflow Limitation in Elderly Adults with a History of Severe Childhood Asthma – COPD-A, COPD-C or?
Irreversible Airflow Limitation in Elderly Adults with a History of Severe Childhood Asthma – COPD-A, COPD-C or?
Abstract
Background
According to the GOLD 2023 strategy paper, classification of chronic obstructive pulmonary disease (COPD) may include distinct COPD types. We applied t...
Lung Deposition of Tanimilast, an Inhaled Phosphodiesterase-4 Inhibitor, Assessed by Functional Respiratory Imaging in Asthma and COPD
Lung Deposition of Tanimilast, an Inhaled Phosphodiesterase-4 Inhibitor, Assessed by Functional Respiratory Imaging in Asthma and COPD
Abstract
Rationale: Tanimilast is an inhaled Phosphodiesterase-4 Inhibitor under development for treatment of asthma and COPD administered via NEXThaler, a dry po...
How we teach children with asthma to use their inhaler: A scoping review protocol
How we teach children with asthma to use their inhaler: A scoping review protocol
Abstract
BackgroundOne reason that asthma remains poorly controlled in children is poor inhaler technique. Current guidelines recommend checking inhaler technique at each c...

